Wellgistics Health (NASDAQ: WGRX) is a Tampa, Florida-based digital health company that integrates telemedicine, diagnostic testing and last-mile logistics into a unified platform. Through its proprietary technology, the company connects patients, healthcare providers and laboratories, enabling real-time virtual consultations alongside at-home specimen collection and direct delivery of prescription medications and supplies. By streamlining clinical workflows and automating logistics, Wellgistics Health aims to improve patient access to care while reducing administrative burden for medical practices.
Founded in 2018 by a team of healthcare and technology veterans, Wellgistics Health launched its telehealth service line in early 2019 and added in-home diagnostic capabilities later that year. In 2021, the company completed a business combination with a special purpose acquisition company (SPAC) and began trading on the Nasdaq under the ticker WGRX. In mid-2023, it rebranded as Wellgistics Health to reflect its expanded focus on end-to-end care delivery and supply-chain solutions within the broader health ecosystem.
Wellgistics Health currently serves patients across more than 30 U.S. states through partnerships with regional health systems, insurers and employer groups. Its offerings include chronic disease management programs, pre-procedure screening services and COVID-19 testing logistics, all supported by an on-demand network of certified phlebotomists and courier partners. The company is also exploring strategic alliances in Canada and Western Europe to extend its digital health and logistics framework internationally.
The company’s leadership team combines clinical, operational and technology expertise. Chief Executive Officer Jessica Taylor previously led product development at a leading telehealth organization, while Chief Operating Officer Sarah Lee brings over a decade of experience in medical supply-chain management. Together with Chief Financial Officer Mark Reynolds, Wellgistics Health’s executive team is focused on scaling its platform, enhancing clinical outcomes and driving partner adoption in an increasingly virtualized care environment.
AI Generated. May Contain Errors.
